Targeted Immobilization of Radiotherapeutics in the Cancer Tumor Microenvironment
NCBiotech Grants & Loans
See the full listing of all NCBiotech grants and loans awarded since July 2012.
Organization
Oncurie, Inc.
Award Date
Award Amount
250,000
Program Name
Small Business Research Loan
Program Category
Business Financing
Principal Investigator
Nicholas "Nick" Trotta
Fiscal Year
2022
Region
Research Triangle
Project Description:
Oncurie is developing targeted radionuclide therapeutics to treat metastatic cancer. These mTRAP compounds are engineered to gather, polymerize, and immobilize near cancer cells, while passing harmlessly by normal, healthy tissues. Oncurie was awarded $250,000 in SRL funding to evaluate the systemic administration of mTRAP compounds in murine breast cancer models.